Centene Corp. has made an initial, strategic investment in RxAdvance Corp., a full-service pharmacy benefit manager.
As part of the initial transaction, Centene has certain rights to expand its equity investment in the future.
RxAdvance founder and CEO Ravi Ika will continue in his current role as CEO of the company and John Sculley will remain chairman and chief marketing officer. Jesse Hunter, Centene's executive vice president of mergers and acquisitions and chief strategy officer, joined RxAdvance's board, effective March 13.
